Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |